Imdusiran
- Generic Name
- Imdusiran
Study of Imdusiran (AB-729) in Combination With Intermittent Dosing of Durvalumab in Subjects With Chronic HBV Infection
- First Posted Date
- 2024-02-07
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- Arbutus Biopharma Corporation
- Registration Number
- NCT06245291
- Locations
- 🇨🇳
China Medical University Hospital, Taichung City, Taiwan
🇹ðŸ‡The Hiv Netherlands Australia Thailand Research Collaboration, Bangkok, Thailand
🇨🇳Chia-yi Christian Hospital, Chia-Yi City, Taiwan
Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection
- Conditions
- Chronic Hepatitis b
- Interventions
- Drug: Peg-IFNα-2a
- First Posted Date
- 2021-07-28
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Arbutus Biopharma Corporation
- Target Recruit Count
- 43
- Registration Number
- NCT04980482
- Locations
- 🇺🇸
Arizona Liver Health, Tucson, Arizona, United States
🇺🇸Research and Education, Inc., San Diego, California, United States
🇺🇸University of Miami Miller School of Medicine, Miami, Florida, United States
A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection
- Conditions
- Hepatitis DHepatitis B, Chronic
- Interventions
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2022-11-18
- Lead Sponsor
- Antios Therapeutics, Inc
- Target Recruit Count
- 40
- Registration Number
- NCT04847440
- Locations
- 🇲🇩
Republican Clinical Hospital "Timofei Mosneaga" Arensia EM Unit, Chisinau, Republic Of Moldova, Moldova, Republic of
🇺🇦Medical Center of Limited Liability Company "Harmoniya krasy", Kyiv, Ukraine
A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2023-11-14
- Lead Sponsor
- Assembly Biosciences
- Target Recruit Count
- 65
- Registration Number
- NCT04820686
- Locations
- 🇧🇬
University Multiprofile Hospital for Active Treatment St. Ivan Rilski, Sofia, Bulgaria
🇨🇦University Hospital - London Health Sciences Centre, London, Ontario, Canada
🇦🇺Liverpool Hospital, Liverpool, New South Wales, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.